Gene

Search results

No.

KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related

Alcoholism 💬

[1] DDC 💬

Benserazide 💬

Benserazide

[1] 6 💬

Alcoholism 💬

[1] DDC 💬

Carbidopa 💬

Carbidopa

[7] 6 , 13, 17, 90, 140, 164, 201 💬

Disease ID	Name
6	Parkinson disease;Disease Parkinson's;
13	Multiple sclerosis/Neuromyelitis optica;
17	Multiple system atrophy;MSA-C;MSA-P;
90	Retinitis pigmentosa;
140	Dorabe syndrome;Dravet syndrome;
164	Oculocutaneous albinism;
201	Angelman syndrome;

Amphetamine addiction 💬

[1] DDC 💬

Benserazide 💬

Benserazide

[1] 6 💬

Amphetamine addiction 💬

[1] DDC 💬

Carbidopa 💬

Carbidopa

[7] 6 , 13, 17, 90, 140, 164, 201 💬

Disease ID	Name
6	Parkinson disease;Disease Parkinson's;
13	Multiple sclerosis/Neuromyelitis optica;
17	Multiple system atrophy;MSA-C;MSA-P;
90	Retinitis pigmentosa;
140	Dorabe syndrome;Dravet syndrome;
164	Oculocutaneous albinism;
201	Angelman syndrome;

Cocaine addiction 💬

[1] DDC 💬

Benserazide 💬

Benserazide

[1] 6 💬

Cocaine addiction 💬

[1] DDC 💬

Carbidopa 💬

Carbidopa

[7] 6 , 13, 17, 90, 140, 164, 201 💬

Disease ID	Name
6	Parkinson disease;Disease Parkinson's;
13	Multiple sclerosis/Neuromyelitis optica;
17	Multiple system atrophy;MSA-C;MSA-P;
90	Retinitis pigmentosa;
140	Dorabe syndrome;Dravet syndrome;
164	Oculocutaneous albinism;
201	Angelman syndrome;

Dopaminergic synapse 💬

[1] DDC 💬

Benserazide 💬

Benserazide

[1] 6 💬

Dopaminergic synapse 💬

[1] DDC 💬

Carbidopa 💬

Carbidopa

[7] 6 , 13, 17, 90, 140, 164, 201 💬

Disease ID	Name
6	Parkinson disease;Disease Parkinson's;
13	Multiple sclerosis/Neuromyelitis optica;
17	Multiple system atrophy;MSA-C;MSA-P;
90	Retinitis pigmentosa;
140	Dorabe syndrome;Dravet syndrome;
164	Oculocutaneous albinism;
201	Angelman syndrome;

Metabolic pathways 💬

[1] DDC 💬

Benserazide 💬

Benserazide

[1] 6 💬

Metabolic pathways 💬

[1] DDC 💬

Carbidopa 💬

Carbidopa

[7] 6 , 13, 17, 90, 140, 164, 201 💬

Disease ID	Name
6	Parkinson disease;Disease Parkinson's;
13	Multiple sclerosis/Neuromyelitis optica;
17	Multiple system atrophy;MSA-C;MSA-P;
90	Retinitis pigmentosa;
140	Dorabe syndrome;Dravet syndrome;
164	Oculocutaneous albinism;
201	Angelman syndrome;

Phenylalanine metabolism 💬

[1] DDC 💬

Benserazide 💬

Benserazide

[1] 6 💬

Phenylalanine metabolism 💬

[1] DDC 💬

Carbidopa 💬

Carbidopa

[7] 6 , 13, 17, 90, 140, 164, 201 💬

Disease ID	Name
6	Parkinson disease;Disease Parkinson's;
13	Multiple sclerosis/Neuromyelitis optica;
17	Multiple system atrophy;MSA-C;MSA-P;
90	Retinitis pigmentosa;
140	Dorabe syndrome;Dravet syndrome;
164	Oculocutaneous albinism;
201	Angelman syndrome;

Serotonergic synapse 💬

[1] DDC 💬

Benserazide 💬

Benserazide

[1] 6 💬

Serotonergic synapse 💬

[1] DDC 💬

Carbidopa 💬

Carbidopa

[7] 6 , 13, 17, 90, 140, 164, 201 💬

Disease ID	Name
6	Parkinson disease;Disease Parkinson's;
13	Multiple sclerosis/Neuromyelitis optica;
17	Multiple system atrophy;MSA-C;MSA-P;
90	Retinitis pigmentosa;
140	Dorabe syndrome;Dravet syndrome;
164	Oculocutaneous albinism;
201	Angelman syndrome;

Tryptophan metabolism 💬

[1] DDC 💬

Benserazide 💬

Benserazide

[1] 6 💬

Tryptophan metabolism 💬

[1] DDC 💬

Carbidopa 💬

Carbidopa

[7] 6 , 13, 17, 90, 140, 164, 201 💬

Disease ID	Name
6	Parkinson disease;Disease Parkinson's;
13	Multiple sclerosis/Neuromyelitis optica;
17	Multiple system atrophy;MSA-C;MSA-P;
90	Retinitis pigmentosa;
140	Dorabe syndrome;Dravet syndrome;
164	Oculocutaneous albinism;
201	Angelman syndrome;

Tyrosine metabolism 💬

[1] DDC 💬

Benserazide 💬

Benserazide

[1] 6 💬

Tyrosine metabolism 💬

[1] DDC 💬

Carbidopa 💬

Carbidopa

[7] 6 , 13, 17, 90, 140, 164, 201 💬

Disease ID	Name
6	Parkinson disease;Disease Parkinson's;
13	Multiple sclerosis/Neuromyelitis optica;
17	Multiple system atrophy;MSA-C;MSA-P;
90	Retinitis pigmentosa;
140	Dorabe syndrome;Dravet syndrome;
164	Oculocutaneous albinism;
201	Angelman syndrome;